DHTKD1 and cancer: Thus, the synthesis and specific action of the OADH inhibitor AP, characterized in this work, provide a useful tool for deciphering cell-specific molecular mechanisms which underlie the known associations between the DHTKD1 expression with diabetes, obesity and cancer.